Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | AHR | P35869 | 2/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.41 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | TNKS | O95271 | 1/20 | 0.40 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.38 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.38 |
| ▸ | IDO1 | P14902 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18271575 | 0.85 | AHR (0.41) | MAPTKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL3046955 | 0.85 | MAPT (0.49) | MAPTKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL30513484 | 0.85 | MAPT (0.49) | MAPTKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL26750757 | 0.84 | HPGD (0.52) | MAPTKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL22376992 | 0.83 | ALOX5 (0.46) | MAPTKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL21283017 | 0.82 | MAPT (0.57) | MAPTKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL18731994 | 0.81 | AHR (0.54) | MAPTKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL18732009 | 0.81 | AHR (0.54) | MAPTKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL16801079 | 0.81 | MAPT (0.49) | MAPTKDM4EALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL21430424 | 0.81 | PLA2G2A (0.46) | MAPTKDM4EALDH1A1HPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12022729-B2 | Compound for organic electric element, organic electric element comprising the same, and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2024-06-25 | — | — | US | disclosed |
| US-12022729-B2 | Compound for organic electric element, organic electric element comprising the same, and electronic device thereof | DUK SAN NEOLUX CO., LTD. (KR) | 2024-06-25 | — | — | US | disclosed |
| EP-3754737-B1 | ORGANIC COMPOUND FOR ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DIODE INCLUDING SAME | SFC CO LTD (KR) | 2023-08-16 | — | — | EP | disclosed |
| US-20200403165-A1 | ORGANIC COMPOUND FOR ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DIODE INCLUDING SAME | SFC CO., LTD. (KR) | 2020-12-24 | — | — | US | disclosed |
| EP-3754737-A1 | ORGANIC COMPOUND FOR ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DIODE INCLUDING SAME | SFC Co., Ltd. (KR) | 2020-12-23 | — | — | EP | disclosed |
| US-20180226585-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC APPARATUS THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2018-08-09 | — | — | US | disclosed |
| US-20120112179-A1 | FLUORANTHENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-05-10 | — | — | US | disclosed |
| US-20120112179-A1 | FLUORANTHENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12022729-B2 | Compound for organic electric element, organic electric element comprising the same, and electronic device thereof | PIEZO1, VDAC2, ORAI2 | MAPT 616/4885KDM4E 440/4885ALDH1A1 1855/4885 |
| US-20120112179-A1 | FLUORANTHENE COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING SAME | AFF1, TCF12, AFF2 | MAPT 3978/4885KDM4E 3677/4885ALDH1A1 772/4885 |
| US-20180226585-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC APPARATUS THEREOF | PIEZO1, ORAI2, VDAC2 | MAPT 1079/4885KDM4E 518/4885ALDH1A1 1529/4885 |
| US-20200403165-A1 | ORGANIC COMPOUND FOR ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DIODE INCLUDING SAME | CHRM1, ORMDL3, MAP1LC3B | MAPT 365/4885KDM4E 2981/4885ALDH1A1 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.